From systemic to oral: Unifying immunological mechanisms via the gut microbiome axis
- 1Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 3Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Abstract
While the gut microbiome regulates host homeostasis and systemic disease via the gut-immune axis, its potential role in regulating oral diseases remains underexplored. This review examines how established gut microbiome-immune mechanisms may contribute to oral inflammation and their therapeutic potential. Gut microbiome dysbiosis may influence oral diseases through microbial metabolites, intestinal barrier dysfunction, inflammatory signaling, and immune regulation. Evidence from systemic diseases supports these mechanisms and provides a rationale for microbiome-targeted approaches, including probiotics, dietary interventions, and fecal microbiota transplantation. However, direct clinical evidence in oral diseases remains limited and heterogeneous. Future research should clarify bidirectional gut-oral interactions, standardize microbiome assessment and clinical outcomes. Well-designed clinical studies are needed to address these limitations and translate the gut-oral axis into meaningful interventions.
Related
- The Oral–Gut–Systemic Axis in Periodontitis: Microbiome Dysbiosis, Immune Crosstalk and Translational Perspectives
- Oral Microbiome–Host Epigenetic Interactions in Oral Carcinogenesis: A Molecular Perspective
- Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease‐Free Survival in Osteosarcoma Patients
- Sulfate ions promote Cnm-mediated aggregation in Streptococcus mutans: molecular dynamics insights into the oral–systemic connection
- Microbial dysbiosis and treatment-related gastrointestinal adverse events in locoregionally advanced nasopharyngeal carcinoma: an exploratory study of the oral and gut microbiome
BibTeX
@article{yuan2026from,
title = {{From systemic to oral: Unifying immunological mechanisms via the gut microbiome axis}},
author = {Xinya Yuan and Linrui Wu and Yaxin Wang and Yuanyuan Zhao and Liqun Zhou and Jiajia Zhao},
journal = {Virulence},
year = {2026},
month = nov,
doi = {10.1080/21505594.2026.2750615},
url = {https://doi.org/10.1080/21505594.2026.2750615},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - From systemic to oral: Unifying immunological mechanisms via the gut microbiome axis
AU - Xinya Yuan
AU - Linrui Wu
AU - Yaxin Wang
AU - Yuanyuan Zhao
AU - Liqun Zhou
AU - Jiajia Zhao
PY - 2026
DA - 2026/11/06
JO - Virulence
DO - 10.1080/21505594.2026.2750615
UR - https://doi.org/10.1080/21505594.2026.2750615
AB - While the gut microbiome regulates host homeostasis and systemic disease via the gut-immune axis, its potential role in regulating oral diseases remains underexplored. This review examines how established gut microbiome-immune mechanisms may contribute to oral inflammation and their therapeutic potential. Gut microbiome dysbiosis may influence oral diseases through microbial metabolites, intestinal barrier dysfunction, inflammatory signaling, and immune regulation. Evidence from systemic diseases supports these mechanisms and provides a rationale for microbiome-targeted approaches, including probiotics, dietary interventions, and fecal microbiota transplantation. However, direct clinical evidence in oral diseases remains limited and heterogeneous. Future research should clarify bidirectional gut-oral interactions, standardize microbiome assessment and clinical outcomes. Well-designed clinical studies are needed to address these limitations and translate the gut-oral axis into meaningful interventions.
SN - 2150-5594
SN - 2150-5608
ER -